MARDIROSSIAN, MARIO
 Distribuzione geografica
Continente #
NA - Nord America 3.726
EU - Europa 2.580
AS - Asia 2.493
SA - Sud America 336
Continente sconosciuto - Info sul continente non disponibili 245
AF - Africa 95
OC - Oceania 11
Totale 9.486
Nazione #
US - Stati Uniti d'America 3.596
IT - Italia 850
SG - Singapore 767
CN - Cina 637
PL - Polonia 550
SE - Svezia 298
BR - Brasile 270
VN - Vietnam 228
HK - Hong Kong 226
BD - Bangladesh 169
FR - Francia 142
DE - Germania 133
KR - Corea 116
GB - Regno Unito 94
FI - Finlandia 91
IN - India 85
RU - Federazione Russa 84
CA - Canada 72
NL - Olanda 67
TR - Turchia 59
UA - Ucraina 55
JP - Giappone 48
IE - Irlanda 43
MA - Marocco 43
BG - Bulgaria 40
MX - Messico 31
CH - Svizzera 22
AR - Argentina 21
IQ - Iraq 18
PK - Pakistan 18
AT - Austria 17
HR - Croazia 17
BE - Belgio 16
CZ - Repubblica Ceca 16
ES - Italia 16
ID - Indonesia 16
ZA - Sudafrica 15
TW - Taiwan 14
SA - Arabia Saudita 13
TH - Thailandia 11
AU - Australia 10
PH - Filippine 10
SN - Senegal 10
CO - Colombia 9
KE - Kenya 9
MY - Malesia 9
PE - Perù 9
CR - Costa Rica 8
EC - Ecuador 8
UZ - Uzbekistan 7
EG - Egitto 6
DK - Danimarca 5
HU - Ungheria 5
NP - Nepal 5
RO - Romania 5
AE - Emirati Arabi Uniti 4
BO - Bolivia 4
GR - Grecia 4
IR - Iran 4
KZ - Kazakistan 4
PY - Paraguay 4
VE - Venezuela 4
EU - Europa 3
IL - Israele 3
MN - Mongolia 3
NI - Nicaragua 3
TT - Trinidad e Tobago 3
XK - ???statistics.table.value.countryCode.XK??? 3
AZ - Azerbaigian 2
BB - Barbados 2
BH - Bahrain 2
CI - Costa d'Avorio 2
CL - Cile 2
DZ - Algeria 2
ET - Etiopia 2
GE - Georgia 2
GT - Guatemala 2
GY - Guiana 2
HN - Honduras 2
JM - Giamaica 2
JO - Giordania 2
KG - Kirghizistan 2
LK - Sri Lanka 2
PA - Panama 2
PT - Portogallo 2
RS - Serbia 2
UY - Uruguay 2
AL - Albania 1
BN - Brunei Darussalam 1
BW - Botswana 1
BY - Bielorussia 1
CM - Camerun 1
DO - Repubblica Dominicana 1
GD - Grenada 1
GH - Ghana 1
KH - Cambogia 1
LB - Libano 1
LT - Lituania 1
LU - Lussemburgo 1
LV - Lettonia 1
Totale 9.236
Città #
Singapore 500
Warsaw 496
Ashburn 493
Trieste 291
San Jose 256
Fairfield 250
Chandler 219
Hong Kong 216
Beijing 186
Woodbridge 153
Council Bluffs 140
Wilmington 115
Houston 108
Seoul 106
Ann Arbor 96
Seattle 96
Hefei 90
Columbus 80
Ho Chi Minh City 76
Los Angeles 72
Cambridge 66
Milan 65
Boardman 64
Princeton 64
Jacksonville 63
New York 62
Chicago 57
Helsinki 55
Hanoi 50
Santa Clara 48
Lauterbourg 46
Dallas 41
Dublin 41
Casablanca 40
Sofia 39
The Dalles 39
Redmond 37
Zgierz 35
Frankfurt am Main 34
Rome 33
London 31
Buffalo 30
Izmir 29
Moscow 29
Phoenix 26
Nuremberg 24
São Paulo 24
Tokyo 24
North Bergen 23
Orem 23
Dearborn 21
Munich 19
Ottawa 19
Nanjing 18
Toronto 17
Bologna 16
Porto Alegre 16
Pune 16
Venice 16
Chennai 15
Lappeenranta 15
Da Nang 14
Dong Ket 14
Falls Church 14
Washington 14
Brooklyn 13
Brussels 13
Turin 13
Amsterdam 12
Atlanta 12
Des Moines 12
Paris 12
Vienna 12
Guangzhou 11
Mexico City 11
Montreal 11
Shanghai 11
Bern 10
Dakar 10
Redondo Beach 10
Rio de Janeiro 10
San Diego 10
Taipei 10
Brno 9
Düsseldorf 9
Hangzhou 9
Miano 9
Naples 9
Norwalk 9
Austin 8
Baghdad 8
Bremen 8
Changsha 8
Kunming 8
Manchester 8
San José 8
Denver 7
Florence 7
Johannesburg 7
Nairobi 7
Totale 5.866
Nome #
D-BMAP18 antimicrobial peptide is active In Vitro, resists to pulmonary proteases but loses its activity in a murine model of Pseudomonas aeruginosa lung infection 391
Structure of the mammalian antimicrobial peptide Bac7(1-16) bound within the exit tunnel of a bacterial ribosome 385
Myticalins: A novel multigenic family of linear, cationic antimicrobial peptides from marine mussels (Mytilus spp.) 385
Proline-rich antimicrobial peptides targeting protein synthesis 372
Antibacterial Electrospun Polycaprolactone Membranes Coated with Polysaccharides and Silver Nanoparticles for Guided Bone and Tissue Regeneration 307
Sviluppo e caratterizzazione di scaffold a base di polisaccaridi con proprietà antimicrobiche per la rigenerazione tissutale 303
Anisaxins, helical antimicrobial peptides from marine parasites, kill resistant bacteria by lipid extraction and membrane disruption 286
The Dolphin Proline-Rich Antimicrobial Peptide Tur1A Inhibits Protein Synthesis by Targeting the Bacterial Ribosome 282
Induced expression of cathelicidins in trout (Oncorhynchus mykiss) challenged with four different bacterial pathogens 258
In vitro and in vivo evaluation of BMAP-derived peptides for the treatment of cystic fibrosis-related pulmonary infections 258
Non-Membrane Permeabilizing Modes of Action of Antimicrobial Peptides on Bacteria 251
Antibacterial rifampicin-loaded electrospun polycaprolactone membranes for ureteral regeneration 239
Proteolytic Activity of Escherichia coli Oligopeptidase B Against Proline-Rich Antimicrobial Peptides. 237
Methods for elucidating the mechanism of action of proline-rich and other non-lytic antimicrobial peptides 234
L-PRF Enrichment with Nanohydroxiapatite: An In Vitro Proof of Concept Study 233
Rifampicin-loaded electrospun polycaprolactone membranes: Characterization of stability, antibacterial effects and urotheliocytes proliferation 232
Search for Shorter Portions of the Proline-Rich Antimicrobial Peptide Fragment Bac5(1–25) That Retain Antimicrobial Activity by Blocking Protein Synthesis 216
Peptide Inhibitors of Bacterial Protein Synthesis with Broad Spectrum and SbmA-Independent Bactericidal Activity against Clinical Pathogens 213
Inner membrane proteins YgdD and SbmA are required for the complete susceptibility of escherichia coli to the proline-rich antimicrobial peptide arasin 1(1–25) 210
Antimicrobial activity of amphiphilic nanomicelles loaded with curcumin against Pseudomonas aeruginosa alone and activated by blue laser light 210
Cathelicidins—a rich seam of antimicrobial peptides waiting for exploitation 196
The anti-pseudomonal peptide d-bmap18 is active in cystic fibrosis sputum and displays anti-inflammatory in vitro activity 190
Fragments of the nonlytic proline-rich antimicrobial peptide Bac5 kill Escherichia coli cells by inhibiting protein synthesis 185
Lipopolysaccharide phosphorylation by the WaaY kinase affects the susceptibility of Escherichia coli to the human antimicrobial peptide LL-37 181
Characterization of cetacean proline-rich antimicrobial peptides displaying activity against eskape pathogens 173
Potential novel therapeutic strategies in cystic fibrosis: antimicrobial and anti-biofilm activity of natural and designed α-helical peptides against Staphylococcus aureus, Pseudomonas aeruginosa, and Stenotrophomonas maltophilia 170
Designing New Hybrid Antibiotics: Proline-Rich Antimicrobial Peptides Conjugated to the Aminoglycoside Tobramycin 168
Effects of lipidation on a proline-rich antibacterial peptide 166
Elastase-Activated Antimicrobial Peptide for a Safer Pulmonary Treatment of Cystic Fibrosis Infections 164
null 163
Core-shell electrospun polycaprolactone nanofibers, loaded with rifampicin and coated with silver nanoparticles, for tissue engineering applications 156
Novel synthesis of 1,2-diaza-1,3-dienes with potential biological activity from cinnamic acids and diazonium salts of anilines 153
Proline-Rich Peptides with Improved Antimicrobial Activity against E. coli, K. pneumoniae, and A. baumannii 148
The proline-rich myticalins from Mytilus galloprovincialis display a membrane-permeabilizing antimicrobial mode of action 144
Paenilamicins are context-specific translocation inhibitors of protein synthesis 142
Polyetheretherketone and titanium surface treatments to modify roughness and wettability – Improvement of bioactivity and antibacterial properties 141
The host antimicrobial peptide Bac71-35 binds to bacterial ribosomal proteins and inhibits protein synthesis 138
Advantages of agarose on alginate for the preparation of polysaccharide/hydroxyapatite porous bone scaffolds compatible with a proline-rich antimicrobial peptide 138
Antimicrobial Peptide with a Bent Helix Motif Identified in Parasitic Flatworm Mesocestoides corti 134
The proline-rich antimicrobial peptide B7-005: low bacterial resistance, safe for human cells and effective in zebrafish embryo bacteraemia model 133
Recent applications of retro-inverso peptides 124
Natural and synthetic halogenated amino acids—structural and bioactive features in antimicrobial peptides and peptidomimetics 113
Structural and biological characterization of shortened derivatives of the cathelicidin PMAP-36 113
Unveiling the Impact of Gene Presence/Absence Variation in Driving Inter-Individual Sequence Diversity within the CRP-I Gene Family in Mytilus spp 104
Identification of genes involved in the resistance to the human antimicrobial peptide LL-37 in E. coli 95
Potential novel therapeutic strategies in cystic fibrosis: Antimicrobial and anti-biofilm activity of natural and designed -helical peptides against Staphylococcus aureus, Pseudomonas aeruginosa, and Stenotrophomonas maltophilia 67
Testing antimicrobial peptides inhibiting protein synthesis in living E. coli and K. pneumoniae using bio-orthogonal non-canonical amino-acid tagging 46
Fragments of cathelicidins PMAP-36 and BMAP-27 and their D-enantiomers: Effects of all D substitutions on structure, protease resistance and antimicrobial properties 28
The structure of the Vibrio natriegens 70S ribosome in complex with the proline-rich antimicrobial peptide Bac5(1–17) 26
Designing New Chimeric Proline-Rich Antimicrobial Peptides to Enhance Efficacy Toward the ESKAPE+E: Beyond Sequence Extension 25
Comparative analysis of lignin peroxidase and laccase responses to graphene-related nanomaterials 23
Two Shorter Variants of the Proline-Rich Antimicrobial Peptide B7-005 Scaffold Active Against Clinical Isolates of Pseudomonas aeruginosa and Staphylococcus aureus 20
Mechanistic Divergence and Differential Antibacterial Potency of the Proline-Rich Antimicrobial Peptide B7-005 Across ESKAPE + E Pathogens 17
Totale 9.486
Categoria #
all - tutte 27.362
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.362


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022457 0 0 49 67 26 29 24 15 59 44 37 107
2022/2023797 73 107 51 131 67 115 20 72 63 21 41 36
2023/2024660 31 36 56 26 71 75 115 97 24 24 59 46
2024/20251.455 24 53 65 155 142 141 92 85 184 225 138 151
2025/20263.586 363 158 199 314 293 276 426 116 386 506 341 208
2026/2027484 167 214 103 0 0 0 0 0 0 0 0 0
Totale 9.486